Existing Unitholders: Please note the Antipodes Emerging Markets (Managed Fund) changed name from the Antipodes Asia Fund on 1 October 2022. Read more
The Fund typically invests in a select number of attractively valued companies exposed to emerging markets or listed on emerging market stock exchanges (usually a minimum 30 long holdings).
|wdt_ID||Share class (accumulating shares)||Detail|
|31 Oct 2022||1 month||-6.4||-2.6||-3.8|
|31 Oct 2022||Inception||-6.4||-2.6||-3.8|
All returns are net of fees and in AUD terms. Past performance is not a reliable indicator of future performance. 1The inception date is the date that the current investment strategy was adopted (1 October 2022). 2MSCI Emerging Markets Index in AUD.
All returns are net of fees and in AUD terms. Calculations are based on exit price with distributions reinvested, after ongoing fees and expenses but excluding taxation. Past performance is not a reliable indicator of future performance. The inception date is the date that the current investment strategy was adopted (1 October 2022).
|Date||Entry price||NAV||Exit price||Distribution|
|04 Oct 2022||0.8971||0.89||0.8917|
|05 Oct 2022||0.9171||0.91||0.9117|
|06 Oct 2022||0.9162||0.91||0.9108|
|07 Oct 2022||0.9026||0.90||0.8972|
|10 Oct 2022||0.8993||0.90||0.8939|
|11 Oct 2022||0.8757||0.87||0.8705|
|12 Oct 2022||0.8738||0.87||0.8686|
|13 Oct 2022||0.8704||0.87||0.8652|
|14 Oct 2022||0.8667||0.86||0.8615|
|17 Oct 2022||0.8702||0.87||0.8650|
|18 Oct 2022||0.8749||0.87||0.8697|
|19 Oct 2022||0.8592||0.86||0.8540|
|20 Oct 2022||0.8496||0.85||0.8446|
|21 Oct 2022||0.8599||0.86||0.8547|
|24 Oct 2022||0.8311||0.83||0.8261|
|25 Oct 2022||0.8227||0.82||0.8177|
|26 Oct 2022||0.8246||0.82||0.8196|
|27 Oct 2022||0.8249||0.82||0.8199|
|28 Oct 2022||0.8175||0.82||0.8127|
|31 Oct 2022||0.8215||0.82||0.8165|
|01 Nov 2022||0.8422||0.84||0.8372|
|02 Nov 2022||0.8407||0.84||0.8357|
|03 Nov 2022||0.8522||0.85||0.8472|
|04 Nov 2022||0.8597||0.86||0.8545|
|07 Nov 2022||0.8640||0.86||0.8588|
|08 Nov 2022||0.8600||0.86||0.8548|
|09 Nov 2022||0.8665||0.86||0.8613|
|10 Nov 2022||0.8505||0.85||0.8455|
|11 Nov 2022||0.8907||0.89||0.8853|
|14 Nov 2022||0.9006||0.90||0.8952|
|15 Nov 2022||0.9247||0.92||0.9191|
|16 Nov 2022||0.9106||0.91||0.9052|
|17 Nov 2022||0.9213||0.92||0.9157|
|18 Nov 2022||0.9119||0.91||0.9065|
|21 Nov 2022||0.9080||0.91||0.9026|
|22 Nov 2022||0.8967||0.89||0.8913|
|23 Nov 2022||0.8872||0.88||0.8818|
|24 Nov 2022||0.8950||0.89||0.8896|
|25 Nov 2022||0.8941||0.89||0.8887|
|28 Nov 2022||0.8893||0.89||0.8839|
|29 Nov 2022||0.9167||0.91||0.9113|
|30 Nov 2022||0.9422||0.94||0.9366|
|wdt_ID||Date||Distribution (A$ per unit)||Reinvestment price (A$ per unit)|
|PT Bank Mandiri (Persero)||Indonesia||4.8|
|Fomento Economico Mexicano||Mexico||4.4|
|PT Astra International||Indonesia||4.4|
|Teck Resources Limited||Canada||3.8|
|Consumer & Commercial Services||6.5||0.0||6.5|
|- China/Hong Kong||27.6||0.0||27.6||0|
|- Rest EM Asia||0.7||0.0||0.7||0|
|Rest of World||3.8||0.0||3.8||1|
1 Where possible, regions, countries and currencies classified on a look through basis. 2 Antipodes Partners classification.
If you are applying online, or using paper application forms, the minimum investment in the Antipodes Emerging Markets (Managed Fund) is $25,000 for new investors and $5,000 for existing investors.
The application below allows you to open an account with our distribution partner; Pinnacle Investment Management Group Pty Ltd (‘Pinnacle’), who focus on providing superior investment services and delivering investment excellence.
Receive live email notifications as the application is processed.
Purchase, top-up or sell a managed fund investment the familiar way.
This fund is open to investors from Australia and New Zealand. For international investors, please visit our international page for investment options.
Online applications are available for individuals, partnerships, SMSFs, superannuation funds and other regulated trusts and companies. Applications for Unregulated Trusts, (such as family and testamentary trusts) cannot be completed online and should make use of the paper based application form in the ‘All forms’ section of this page.
All website content in respect of the Antipodes Emerging Markets (Managed Fund) (ARSN 096 451 393) (the Fund) is issued by Pinnacle Fund Services Limited ABN 29 082 494 371 AFSL 238 371 (“PFSL”) as responsible entity of the Fund and is prepared by Antipodes Partners Limited (ABN 29 602 042 035) (AFSL 481580) (“Antipodes”) as the investment manager of the Trust. PFSL is not licensed to provide financial product advice.
The information provided in this website is of a general nature only and has been prepared without taking into account your objectives, financial situation or needs. Before making an investment decision in respect of the Fund, you should consider the current product disclosure statement (PDS) and Target Market Determination (‘TMD’) of the Fund and the Fund’s other periodic and continuous disclosure announcements lodged with the ASX, which are available at www.asx.com.au, and assess whether the Fund is appropriate given your objectives, financial situation or needs. If you require advice that takes into account your personal circumstances, you should consult a licensed or authorised financial adviser.
Neither PFSL nor Antipodes guarantees repayment of capital or any particular rate of return from the Fund. Neither PFSL nor Antipodes gives any representation or warranty as to the currency, reliability, completeness or accuracy of the information contained in this website. All opinions and estimates included in this website constitute judgments of Antipodes as at the date of website creation and are subject to change without notice. Past performance is not a reliable indicator of future performance.
The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (assigned Antipodes Emerging Markets (Managed Fund) – November 2022) referred to on this website is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.
The Lonsec Ratings (assigned as follows: Antipodes Emerging Markets (Managed Fund) – June 2022) presented in this document are published by Lonsec Research presented in this document are published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421445. The Ratings are limited to “General Advice” (as defined in the Corporations Act 2001 (Cth)) and based solely on consideration of the investment merits of the financial products. Past performance information is for illustrative purposes only and is not indicative of future performance. They are not a recommendation to purchase, sell or hold Antipodes products, and you should seek independent financial advice before investing in these products. The Ratings are subject to change without notice and Lonsec assumes no obligation to update the relevant documents following publication. Lonsec receives a fee from the Fund Manager for researching the products using comprehensive and objective criteria. For further information regarding Lonsec’s Ratings methodology, please refer to our website at https://www.beyond.lonsec.com.au/intelligence/lonsec-ratings.
Evergreen Research Pty Ltd trading as ERIG Index ABN 17 647 506 590 is Authorised Representative 001289533 of Evergreen Fund Managers Pty Ltd ABN 75 602 703 202AFSL 486275. The material is for the information purposes of non-retail clients only.It is not, and is not to be construed as, advice or a recommendation to acquire, hold or dispose of financial products or to use financial services. The ERIG Index measures only the Responsible Investment capabilities of funds. It does not assess the performance or other features of the funds.